Glass House Brands Inc. GLAS

Annual Quarterly

FY2025 · ended Dec 31, 2025 · Revenue $181.98M, -9.4% YoY · Filed Mar 24, 2026

Glass House Brands Inc. (GLAS) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $182.0 million and a net loss of $29.7 million. Free cash flow was -$15.7 million. As of Dec 31, 2025 it held $19.9 million in cash and investments and $74.6 million in total debt.

Revenue
$181.98M
-9.4% vs prior year
Net income
$-29.66M
-5814.6% vs prior year
Operating cash flow
$11.45M
-59.7% vs prior year
Free cash flow
$-15.73M
-186.9% vs prior year
EPS
$-0.55
-161.9% vs prior year
Dividend per share
None
Shares outstanding
—
Net cash
$-54.72M
FY 2025
Operating margin
-9.1%
FY 2025

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
GLAS (NYSE)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Long Beach, CA
SEC filer status
, Emerging growth company
SEC CIK
1848731
Former names
Mercer Park Brand Acquisition Corp. (until Mar 30, 2021)

Other Medicinal Chemicals & Botanical Products companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$182.0M
$200.9M
$160.8M
$84.9M
$63.2M
Operating income
-$16.5M
$5.7M
-$49.5M
-$56.4M
-$36.2M
Net income
-$29.7M
$519,000
-$98.3M
-$32.9M
-$43.1M
Diluted EPS
-$0.55
-$0.21
-$1.62
-$0.83
-$1.11
Operating cash flow
$11.4M
$28.4M
$23.2M
-$40.8M
-$20.3M
Free cash flow
-$15.7M
$18.1M
$10.9M
-$68.6M
-$128.8M
Total assets
$318.6M
$310.5M
$303.8M
$350.6M
$287.6M
Total liabilities
$144.0M
$146.4M
$158.5M
$129.5M
$105.6M
Stockholders' equity
$73.9M
$116.2M
$89.8M
$168.9M
$182.1M
Cash and investments
$19.9M
$36.3M
$31.9M
$15.4M
$58.3M
Total debt
$74.6M
$69.2M
$75.1M
$73.9M
$48.0M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 26, 2026 Oct 26, 2026
6-K Current report (foreign issuer) Oct 19, 2026 Oct 19, 2026
6-K Current report (foreign issuer) Oct 9, 2026 Oct 9, 2026
6-K Current report (foreign issuer) Sep 29, 2026 Sep 29, 2026
6-K Current report (foreign issuer) Sep 11, 2026 Sep 11, 2026
6-K Current report (foreign issuer) Aug 14, 2026 Jun 30, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.